| Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ... The Lancet infectious diseases 15 (10), 1193-1202, 2015 | 616 | 2015 |
| Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study LJ Pankhurst, C del Ojo Elias, AA Votintseva, TM Walker, K Cole, J Davies, ... The Lancet Respiratory Medicine 4 (1), 49-58, 2016 | 369 | 2016 |
| Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131 N Stoesser, AE Sheppard, L Pankhurst, N De Maio, CE Moore, R Sebra, ... MBio 7 (2), e02162-15, 2016 | 298 | 2016 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ ACE project S Moreno‐Grau, I de Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 133 | 2019 |
| PLCG2 protective variant p. P522R modulates tau pathology and disease progression in patients with mild cognitive impairment L Kleineidam, V Chouraki, T Prochnicki, SJ van der Lee, ... Acta neuropathologica 139 (6), 1025-1044, 2020 | 46 | 2020 |
| Multiomics integrative analysis identifies APOE allele-specific blood biomarkers associated to Alzheimer’s disease etiopathogenesis L Madrid, S Moreno-Grau, S Ahmad, A González-Pérez, I de Rojas, R Xia, ... Aging (Albany NY) 13 (7), 9277, 2021 | 19 | 2021 |
| Long runs of homozygosity are associated with Alzheimer’s disease S Moreno-Grau, MV Fernández, I de Rojas, P Garcia-González, ... Translational psychiatry 11 (1), 1-12, 2021 | 9 | 2021 |
| Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease L Madrid, SC Labrador, A González-Pérez, ME Sáez, ... Diagnostics 11 (12), 2303, 2021 | 7 | 2021 |
| Generating temporal network paths from hospital data JM Finney, LM Marquez International Conference on Health Informatics 6, 263-268, 2016 | 1 | 2016 |
| Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease. Diagnostics 2021, 11, 2303 L Madrid, SC Labrador, A González-Pérez, ME Sáez s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| Characterization of transcriptional and proteomics changes in brain cells derived from isogenic hiPSCs reveals cell type–and genotype‐specific mechanisms modified by APOE … JS Ried, MR Curado, ME Sáez, L Bahnassawy, H Lee, P Reinhardt, ... Alzheimer's & Dementia 16, e040280, 2020 | | 2020 |
| Can OMICS data help us to understand the mechanism of APOE? ME Sáez, S Moreno-Grau, L Madrid, A Ramirez, JS Ried, ... 2020 Alzheimer's Association International Conference, 2020 | | 2020 |
| Autosomal Recessive Alzheimer’s disease (arAD): homozygosity mapping of genomic regions containing arAD loci S Moreno-Grau, MV Fernández, I de Rojas, I Hernández, F Farias, ... bioRxiv, 2020 | | 2020 |
| P3‐139: SYSTEMATIC APOE GENOTYPE‐STRATIFIED ANALYSIS OF HUMAN OMICS DATA: A STUDY FROM THE IMI ADAPTED PROJECT L Madrid, B Hernández-Olasagarre, A González-Pérez, JS Ried, ... Alzheimer's & Dementia 14 (7S_Part_21), P1121-P1121, 2018 | | 2018 |
| P3‐131: LOOKING FOR THERAPEUTIC ENTRY POINTS FOR ALZHEIMER'S DISEASE: LESSONS LEARNED FROM AGNOSTIC TRANS‐CO‐REGULATORY NETWORK ANALYSES OF APOE, TREM2, PLCG2 AND ABI3 LOCI A Ruiz, L Madrid, I de Rojas, A González-Pérez, S Mañes, A Ramirez, ... Alzheimer's & Dementia 14 (7S_Part_21), P1117-P1118, 2018 | | 2018 |
